Pay in 4 interest-free payments of $40.62 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
/ 4-Nitrophenyl α-Kojobioside / pNP-α-Kojobioside
providing a straightforward route to conjugate the ligand onto NHS-activated molecules and surfaces
Fmoc-Ser(GlcNAc(Ac)3-β-D)-OH
followed by cleavage of the α-glycosidic bond by α-L-iduronidase (IDUA) to release 4-methylumbelliferone
GA131000: Fmoc-Thr(GalNAc(Ac)3-α-D)-OH Pack Size:500 mg / 4-Nitrophenyl α-Kojobioside / pNP-α-KojobiosideC33H38N2O13 670. 66 An Fmoc protected L threonine building block carrying an D GalNAc residue, designed for solid phase peptide synthesis (SPPS) of glycopeptides. The N Fmoc group is removed under standard base conditions (piperidine) during chain elongation, while the free carboxylic acid is available for coupling to the growing resin bound peptide. The sugar hydroxyl groups are protected as three acetate esters (Ac3), which keep the glycan inert
